Celyad Oncology SA (CLYYF PINK) stock market data APIs
$0.279
0(0%)
as of September 11, 2026
Try our APIs with
free plan!
Celyad Oncology SA Financial Data Overview
Price chart is built with
Anychart
Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.
Prev. Close
0.279
Open
0.279
High
0.279
Low
0.279
52 wk Range
0.15-0.41
Market Cap
20 967 K
P/E Ratio
14
Shares Outstanding
74 883 K
Revenue
21 000
EPS
-0.5483
Beta
1.211
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Celyad Oncology SA data using free add-ons & libraries
Get Celyad Oncology SA Fundamental Data
Celyad Oncology SA Fundamental data includes:
- Net Revenue: 21 000
- EBITDA: -1 520 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-09-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Celyad Oncology SA News
New
Celyad Oncology SA GAAP EPS of -$0.09
* Celyad Oncology SA press release [https://seekingalpha.com/pr/20245001-celyad-oncology-reports-first-half-year-2025-financial-results] (OTC:CLYYF [https://seekingalpha.com/symbol/CLYYF]): 1H GAAP ...
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
Celyad Oncology SA MONT-SAINT-GUIBERT, Belgium, May 31, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biotechnology company focused on th...
Celyad: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
MONT-SAINT-GUIBERT, Belgium, May 31, 2022--(BUSINESS WIRE)--Regulatory news: Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the "Company"), a clinical-stage biotechnology company focused on the discov...
Get Celyad Oncology SA fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
